U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225452) titled 'A Cell-free and Exosomal miRNA-based Liquid Biopsy for ICC Detection' on Nov. 04.
Brief Summary: Intrahepatic cholangiocarcinoma (ICC) is a malignant liver tumor with poor prognosis and limited curative treatment options. Early and accurate detection remains an unmet clinical need.
The LUMIC study aims to develop a non-invasive liquid biopsy platform based on both cell-free and exosomal microRNAs (cf- and exo-miRNAs) to detect intrahepatic cholangiocarcinoma with high sensitivity and specificity.
Study Start Date: June 21, 2024
Study Type: OBSERVATIONAL
Condition:
Intrahepatic Cholangiocarcinoma (Icc)
Intervention:
DIAGNOSTIC_...